Authors

Latest:

Properly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.

Latest:

How AI-powered support automation can solve the data problem in clinical trial management

Latest:

To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.

Latest:

The growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for

Latest:

Making connections between different datasets is essential to developing impactful medicines and driving more personalized patient care.

Latest:

From November 2023, the Drug Supply Chain Security Act requires healthcare manufacturers, distributors, providers, and dispensers to exchange the serialized item-level product information that has been collected, standardized, and digitized. Hitting this deadline hinges on intensive collaboration between manufacturers and their supply chain partners that must begin now

Latest:

Organizations can go a long way toward ushering in the pharmacy of the future and enabling safer, more efficient care by implementing an intelligent infrastructure of technology.

Latest:

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

Latest:

Non-commercial pharmacies can be secret weapons for intake and adherence

Latest:

Pharma’s prime chance to reduce carbon emissions from supply chain

Latest:

Innovation in pharma manufacturing as paradigms shift and biotech and personalized therapies move through clinical trials at pace

Latest:

How privacy and technology literacy can coexist behind a blockchain-based approach to patient data analytics and control

Latest:

There’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.

Latest:

Why they are a game changer, and ways to a adapt to a new era of state privacy regulations.

Latest:

Teams need to keep close track of ingredients, processing parameters, and material performance so that they can use their R&D data to decide exactly which materials to make next.

Latest:

Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26,500 a year.

Latest:

The steps pharma manufacturers can take to mitigate transportation costs amid Covid’s supply-chain crunch

Latest:

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

Latest:

Latest:

Catherine Humphries sheds light on three key market access challenges within the ophthalmology biosimilars space.

Latest:

Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, highlighting a critical need for increased awareness and resources.

Latest:

Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.

Latest:

How recent advancements in practice and technology have ushered in a new era of pharmaceutical logistics.

Latest:

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.

Latest:

A prescription for making the pharma supply chain more resilient, reliable and disruption-proof

Latest:

Alongside the proper temperature-monitoring technology, optimal production control is necessary for success in cold chain drug delivery.

Latest:

Wednesday, October 5, 2022, 11am EDT Market access considerations can be complex to navigate and overwhelming to address for biopharmaceutical commercial teams launching their first specialty drug. Get answers to eleven key questions that will help guide commercial teams in effectively launching specialty products.

Latest:

New federal law introduces significant changes in the design of pharmacy benefit plans with aims to level the playing field between PBMs and their employee healthcare benefit plan clients.

Latest:

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves